$Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study$

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study

Show other versions (1)

<p><strong>Background</strong></p> Bisphosphonates are contraindicated in patients with stage 4+ chronic kidney disease. However, they are widely used to prevent fragility fractures in stage 3 chronic kidney disease, despite a lack of good-quality data on their effects. <...

Full description

Bibliographic Details
Main Authors:	Robinson, DE, Ali, MS, Strauss, VY, Elhussein, L, Abrahamsen, B, Arden, NK, Ben-Shlomo, Y, Caskey, F, Cooper, C, Dedman, C, Delmestri, A, Judge, A, Javaid, M, Prieto-Alhambra, D
Format:	Journal article
Language:	English
Published:	NIHR Journals Library 2021

Similar Items

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
by: Robinson, DE, et al.
Published: (2021)

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis
by: Robinson, DE, et al.
Published: (2021)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
by: Ali, MS, et al.
Published: (2017)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
by: Garriga, C, et al.
Published: (2017)

Use of oral bisphosphonates and bone mineral density changes in moderate-severe (Stage 3B+) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
by: Ali, M, et al.
Published: (2017)

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study
by: Strauss, V, et al.
Published: (2018)

Oral bisphosphonates and chronic kidney disease: progression and safety
by: Prieto-Alhambra, D, et al.
Published: (2018)

Oral bisphosphonate use and all‐cause mortality in patients with advanced (stage IIIB+) chronic kidney disease: a propensity score analysis
by: Alarkawi, D, et al.
Published: (2018)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: A propensity score analysis
by: Prieto-Alhambra, D, et al.
Published: (2011)

Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Oral bisphosphonate use and all-cause mortality in patients with advanced (stage IIIB plus ) chronic kidney disease: a population-based cohort study
by: Alarkawi, D, et al.
Published: (2017)

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
by: Ali, M, et al.
Published: (2018)

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
by: Robinson, D, et al.
Published: (2018)

Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B–5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
by: Ali, MS, et al.
Published: (2020)

The effects of disease-modifying antirheumatic drugs on dementia in patients with rheumatoid arthritis: a population-based propensity-matched cohort study over 15 years
by: Judge, A, et al.
Published: (2017)

Reduction in fracture rates with Denosumab compared to Alendronate in treatment naïve patients: a propensity-matched ‘real world’ cohort and instrumental variable analysis.
by: Khalid, S, et al.
Published: (2017)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
by: Garriga, C, et al.
Published: (2018)

Predictors of second fracture while on treatment with oral bisphosphonates: a multinational cohort study
by: Hawley, S, et al.
Published: (2014)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
by: Garriga, C, et al.
Published: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
by: Garriga, C, et al.
Published: (2018)

BISPHOSPHONATE USE IS ASSOCIATED WITH REDUCED REVISIONS OF LOWER LIMB JOINT (KNEE OR HIP) ARTHROPLASTY: A POPULATION-BASED COHORT STUDY
by: Prieto-Alhambra, D, et al.
Published: (2011)

Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
by: Khalid, S, et al.
Published: (2022)

Three strategies to measure frailty and/or complex health needs in real world data: An analysis of UK primary care and hospital linked data
by: Elhussein, L, et al.
Published: (2020)

The use of preventative treatments (statins, bisphosphates and anti-hypertensives) in older patients with complex health needs: An analysis of UK primary care and linked hospital data
by: He, Y, et al.
Published: (2020)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Comparative risk of venous thromboembolism among users of different anti-osteoporosis drugs in the UK National Health Service and in Catalonia, Spain: A propensity-matched cohort study
by: Khalid, S, et al.
Published: (2017)

ASSOCIATION BETWEEN CHONDROITIN SULPHATE USE AND THE RISK OF TOTAL KNEE ARTRHOPLASTY IN OSTEOARTHITIS PATIENTS: A PROPENSITY-SCORE MATCHED COHORT STUDY
by: Prieto-Alhambra, D, et al.
Published: (2013)

Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
by: Prieto-Alhambra, D, et al.
Published: (2012)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: Population based retrospective cohort study
by: Prieto-Alhambra, D, et al.
Published: (2012)

Random effects modelling vs logistic regression for the inclusion of surgeon covariates in propensity scores for medical device epidemiology: A simulation study
by: Du, M, et al.
Published: (2020)

Comparative risk of acute myocardial infarction among users of different anti-osteoporosis drugs in Catalonia, Spain: A propensity matched cohort study using data from the SIDIAP database
by: Khalid, S, et al.
Published: (2017)

Comparative fracture risk amongst users of different anti-osteoporosis drugs available in the UK in the NHS: A propensity-matched cohort study using data from the Clinical Practice Research Datalink
by: Khalid, S, et al.
Published: (2016)

Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2014)

Comparative risk of venous thromboembolism amongst users of different anti-osteoporosis drugs in the uk: a propensity-matched cohort study using data from the clinical practice research datalink
by: Khalid, S, et al.
Published: (2016)

Bariatric surgery increases the rate of major fracture: self-controlled case series study in UK Clinical Practice Research Datalink
by: Robinson, DE, et al.
Published: (2021)

Major osteoporotic fracture risk following bariatric surgery: a self-controlled case series including 5,492 people from the UK CPRD and linked HES databases
by: Robinson, DE, et al.
Published: (2019)

Bariatric surgery increases the risk of major osteoporotic fracture: a self-controlled case series patients from the CPRD GOLD database linked to HES
by: Robinson, DE, et al.
Published: (2019)

Evaluation of treatment effect modification in propensity score matching: An empirical example
by: Ali, M, et al.
Published: (2018)